Teva Pharmaceutical Industries LimitedTEVA

Where TEVA's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$37.09+0.74 (+2.04%)Previous close
NYSEHealthcare

TEVA Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
TEVA Net Debt / EBITDA historyTEVA Net Debt / EBITDA from Sep 2023 to Jun 2026: low 3.84, high 9.95, latest 5.1.3.355.126.98.6710.44Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 5.16

TEVA Net Debt / EBITDA by year

Yearly range of TEVA’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from -47.7 to 30.6, averaging 1.9.

TEVA Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20264.04.65.15.1
20253.84.85.94.1
20245.37.28.88.8
20234.38.49.94.3
202210.814.824.324.3
2021-20.2-5.87.27.2
2020-14.3-1.413.4-14.2
2019-47.7-17.213.913.9
2018-3.35.530.630.6
2017-13.7-4.611.2-2.1
20167.69.411.211.2

Get notified when TEVA Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.